Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Ketamine/Assisted Therapy

Recent news which mentions Ketamine/Assisted Therapy

EXCLUSIVE: Mindbloom's Mastermind Series, A Psychedelic Therapy Program For Heartbreak, Burnout & Parallel Challenges
Tags Markets Market News Cannabis
From Benzinga
UK Psychedelics: Phase 3 Depression & Alcohol Addiction Trials, New London Center
Tickers AWKNF CMPS
Tags Penny Stocks News Markets
From Benzinga
Ketamine Company Acquisition Alert: Beckley Waves Adds Nue Life To Its Portfolio
Tags Ketamine/Assisted Therapy Beckley Waves Psychedelics
From Benzinga
Psychedelics Firm Optimind Pharma Sustains Growth Plan Rollout With New Acquisition
Tags Psychedelic/Enhanced Psychotherapy News Optimind Pharma Corp
From Benzinga
PsychMD's Nationwide, Safe-Supplied AI-Driven Ketamine Therapy With US Vets In Mind
Tags News Markets Cannabis
From Benzinga
Healthcare Providers Can Offer Ketamine Treatment On Employee Insurance Plans
Tags Psychedelics Benzinga Enthea
From Benzinga
Awakn's Q4 2023 And Annual Financials, +500% YoY Revenue Increase Following Network Expansion
Tickers AWKNF
Tags Markets Market News Cannabis
From Benzinga
Joint Venture Partnership Expands Access To Psychedelics Therapy For Some 50K Patients
Tickers RVLWF
Tags Markets Market News Cannabis
From Benzinga
EXCLUSIVE: NYC Ketamine Center Co-Founder On Prices, Insurance, Competition & Expansion
Tickers ATAI CMPS DMTTF MNMD
Tags Penny Stocks Nushama ATAI
From Benzinga
EXCLUSIVE: Ketamine Therapy Provider Nushama Co-Founder On Shifting From A Consciousness Of Blame Into A Space Of Responsibility
Tickers AWKNF
Tags Market News Cannabis Markets
From Benzinga
EXCLUSIVE: NYC's Premier Ketamine Therapy Provider Nushama Talks Integration, Safety & Holistic Care
Tags News Nushama Exclusives
From Benzinga
Awakn's Ketamine Treatment For Alcohol Use Disorder Awarded UK's Fast-Track Status
Tickers AWKNF
Tags Benzinga Psychedelics AWKNF
From Benzinga
Cybin Touts Promising Results From Sponsored Kernel Flow Study Measuring Psychedelic Effects On The Brain
Tickers CYBN
Tags CYBN Psychedelics Benzinga
From Benzinga
UK Supports Psychedelic Research With Phase 3 Trial In Federal Health Sites
Tickers AWKNF
Tags Phase 3 Clinical Trial News Ketamine/Assisted Therapy
From Benzinga
Free Ketamine Therapy? Laid Off Tech Workers Can Request Month Of 'Freedom' Program
Tickers AMZN META TECH
Tags Markets Offerings META
From Benzinga
Europe To Have Expanded Access To Psychedelic-Assisted Therapy With New Norway Clinic
Tickers AWKNF
Tags AWKNF Benzinga Psychedelics
From Benzinga
A Leading Ketamine Treatment Clinic For Alcoholism Is Expanding: Here's The Latest
Tickers AWKNF
Tags General Management Norway
From Benzinga
Psychedelics And Treatment-Resistant Depression: Companies Weigh In On The Important Issue
Tickers ATAI CMPS
Tags News Psilocybin/Assisted Therapy ATAI
From Benzinga
Psychedelic-Assisted Psychotherapy And Telehealth Platforms Merge To Enhance Treatment Options
Tags Markets Cannabis TripSitter Clinic Ltd/
From Benzinga
Florida Ketamine Therapy Provider Launches Non Profit To Offer Affordable Psychedelic Treatments
Tags MY Self Wellness Cannabis Market News
From Benzinga
EXCLUSIVE: New Partnership Brings Leading Psychedelic Protocol For Alcoholism Treatment To NYC
Tickers AWKNF NYC
Tags NYC News Exclusives
From Benzinga
Florida's Growing Psychedelic Treatment Options: Healthcare Company Expands Network Of Clinics
Tickers IWINF
Tags IWINF Irwin Naturals Emergence Psychedelics
From Benzinga
At Home-Ketamine Therapy Platform: What's It All About?
Tags Guidance News Global
From Benzinga
Intradermal Ketamine Patch Completes Pre-Clinical Phase, Advances To Clinical Studies
Tickers PHRRF
Tags Global Markets Market News
From Benzinga
Awakn Life Sciences: Business And Corporate Update For Psychedelics Biotech
Tickers AWKNF
Tags Project Kestrel AWKNF Psychedelics
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.